Human NgR-Fc Decoy Protein via Lumbar Intrathecal Bolus Administration Enhances Recovery from Rat Spinal Cord Contusion-Reference-Cited by-同舟云学术

Human NgR-Fc Decoy Protein via Lumbar Intrathecal Bolus Administration Enhances Recovery from Rat Spinal Cord Contusion

Published:2014-12-15 Issue:24 Volume:31 Page:1955-1966
ISSN:0897-7151
Container-title:Journal of Neurotrauma
language:en
Short-container-title:Journal of Neurotrauma

Author:

Wang Xingxing¹²,Yigitkanli Kazim¹²,Kim Chang-Yeon¹²,Sekine-Konno Tomoko¹²,Wirak Dana³,Frieden Eric³,Bhargava Ajay⁴,Maynard George³,Cafferty William B.J.²,Strittmatter Stephen M.¹²

Affiliation:

1. Program in Cellular Neuroscience, Neurodegeneration & Repair, and Yale University School of Medicine, New Haven, Connecticut.

2. Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.

3. Axerion Therapeutics, Branford, Connecticut.

4. Shakti BioResearch, Woodbridge, Connecticut.

Publisher

Mary Ann Liebert Inc

Subject

Neurology (clinical)

Link

http://www.liebertpub.com/doi/pdf/10.1089/neu.2014.3355

Reference43 articles.

1. Extracellular regulators of axonal growth in the adult central nervous system

2. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

3. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

4. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How does Nogo-A signalling influence mitochondrial function during multiple sclerosis pathogenesis?;Neuroscience & Biobehavioral Reviews;2024-08

2. Pharmacological intervention for chronic phase of spinal cord injury;Neural Regeneration Research;2024-06-26

3. Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial;Current Opinion in Neurology;2023-09-19

4. Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial;The Lancet Neurology;2023-08

5. How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?;Frontiers in Cellular Neuroscience;2023-06-08